Ionis Pharmaceuticals has been invited to participate in new Medicaid arrangements, coinciding with Donald Trump's promise of globally cheapest drug prices.
1 report, 1 independent
Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ionis Pharmaceuticals has been invited to participate in new Medicaid arrangements, coinciding with Donald Trump's promise of globally cheapest drug prices.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ionis Pharmaceuticals
American pharmaceutical company
Nothing else this week.
-
Medicare
US federal health insurance
Related events
- Trump distributes a rebate to qualified Medicare enrollees.
- CMS introduced the Medicare drug price negotiation program, and companies are facing challenges regarding pricing and market access.
- A report analyzes policy changes under the Trump administration affecting healthcare and Medicare.
- Trump proposed a health care boost for Medicare beneficiaries, which was criticized by Ron Wyden.
- Trump's administration is ending the Part D subsidy for Medicare, while advocates push seniors onto private Medicare Advantage plans.